Related Experiment Video

Updated: Feb 19, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

7.5K

The experience of management of chronic hepatitis B in China

H Ren1

  • 1Department for infectious diseases The second affiliated hospital of Chongqing Medical University, Institute for viral hepatitis Chongqing Medical University, Chongqing, China.

Journal of Viral Hepatitis
|October 31, 2017
PubMed

Insights

China

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Public Health

Background:

  • China has the world's largest population with chronic hepatitis B virus (HBV) infection.
  • Physicians and scientists in China have accumulated 30 years of unique experience in combating HBV.
  • This experience is invaluable despite the use of some outdated therapies.

Discussion:

  • Lessons learned from China's extensive HBV experience can inform global strategies.
  • Understanding historical treatment approaches provides context for current therapeutic development.
  • The long-term management of chronic HBV infection presents unique challenges and insights.

Key Insights:

  • China's 30-year fight against HBV offers critical insights for global health.
  • Past treatment experiences, even with suboptimal drugs, hold significant value.
  • Accumulated clinical and research data are crucial for advancing HBV therapies.

Outlook:

  • Future HBV drug development can leverage China's extensive historical data.
  • New strategies against HBV can be informed by decades of clinical practice.
  • Continued research and international collaboration are essential for HBV eradication.

Keywords:
ChinaPEG-interferonchronic hepatitis Bnucleos(t)ide

More Related Videos

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.7K
Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle09:35

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

14.0K

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
393
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
213
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
259
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
823